Epinephrine and Smell - impaired - a phase IV clinical study of FDA data

Summary:

Smell - impaired is reported as a side effect among people who take Epinephrine (epinephrine), especially for people who are female, 60+ old, also take Acetaminophen, and have Nasal polyps.

The phase IV clinical study analyzes which people have Smell - impaired when taking Epinephrine. It is created by eHealthMe based on reports of 21,223 people who have side effects when taking Epinephrine from the FDA, and is updated regularly.

What is Epinephrine?

Epinephrine has active ingredients of epinephrine. It is often used in asthma. eHealthMe is studying from 21,290 Epinephrine users. Check the latest studies of Epinephrine.

What is Smell - impaired?

Smell - impaired is found to be associated with 647 drugs and 1,211 conditions by eHealthMe. Check the latest studies of Smell - impaired.

On Jul, 20, 2026

21,223 people reported to have side effects when taking Epinephrine.
Among them, 17 people (0.08%) have Smell - impaired.

Could Epinephrine cause Smell - impaired?

Among these 17 people:

What is the gender of people who have Smell - impaired when taking Epinephrine? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Smell - impaired when taking Epinephrine? *

What are other drugs people take besides Epinephrine? *

What are other side effects people have besides Smell - impaired? *

Ageusia (loss of taste functions of the tongue): 7 people, 41.18%
Headache (pain in head): 6 people, 35.29%
Hypersensitivity: 5 people, 29.41%
Fatigue (feeling of tiredness): 5 people, 29.41%
Dyspnea (difficult or laboured breathing): 5 people, 29.41%
Cough: 5 people, 29.41%
Nasal Obstruction (blockage of nose): 4 people, 23.53%
Nasal Polyps (masses that develop in the lining of the nose): 4 people, 23.53%
Diarrhea: 4 people, 23.53%
Drug Hypersensitivity: 3 people, 17.65%

What are the existing conditions these people have? *

Nasal Polyps (masses that develop in the lining of the nose): 3 people, 17.65%
Primary Immunodeficiency Syndrome: 2 people, 11.76%
Immunodeficiency Common Variable: 2 people, 11.76%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.88%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 1 person, 5.88%
Headache (pain in head): 1 person, 5.88%
Food Allergy: 1 person, 5.88%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 5.88%
Cough: 1 person, 5.88%
Asthmatic Crisis: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Epinephrine and have Smell - impaired?

- Check whether Smell - impaired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Epinephrine:

Epinephrine (21,290 reports)

Smell - impaired treatments and more:

Smell - impaired (15,598 reports)

Browse all side effects of Epinephrine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Smell - impaired:

Smell - impaired (647 drugs)

Browse all the conditions that are associated with Smell - impaired:

Smell - impaired (1,211 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epinephrine (the active ingredients of Epinephrine) and Epinephrine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.